You Searched For "vir biotechnology" and got 12 results
Sort By:
1 min read
Vir Biotechnology spikes 36% after it says its COVID-19 treatment reduced hospitalizations and deaths in high-risk patients
The company said it will seek emergency use authorization for the drug in the US and in other count…
Isabelle Lee
3 mins read
GSK just bet $250 million on Vir as the pharma giant and the buzzy biotech team up to hunt for coronavirus treatments and vaccines
Previously, GSK had taken a minor role in coronavirus vaccine work, offering its adjuvant technolog…
Andrew Dunn
1 min read
27 pharma execs involved in the hunt for COVID-19 vaccines have raked in more than $1 billion by selling stock this year. Here's who's cashed in the most from Regeneron, Moderna, Vir, and more.
A Business Insider analysis found 27 biotech insiders who had cashed in more than $10 million in st…
Andrew Dunn
2 mins read
FDA poised to stop monoclonal antibody treatments that are ineffective against the Omicron COVID-19 variant
The FDA is set to halt the COVID-19 treatments made by Eli Lilly and Regeneron, the agency announce…
Jake Epstein
2 mins read
An obscure biotech stock skyrockets 38% after saying it's testing a coronavirus antibody
The Monday gains for the company, which has a market value of about $2.8 billion, are a continuatio…
Carmen Reinicke
5 mins read
Omicron has drug companies preparing for the worst. Here are their plans to counterattack the newest COVID-19 variant.
Experts fear that the newest variant may make vaccines and therapies less effective. "On the face o…
Andrew Dunn
5 mins read
A buzzy Seattle biotech is teaming up with Microsoft and Amgen to hunt for 'the Michael Jordan of antibodies' to fight the coronavirus
Research is now underway to find the best antibodies, or virus-fighting proteins, to use against th…
Andrew Dunn
3 mins read
4 potential coronavirus treatments that researchers are working on right now
"There's a potential that they could be used prophylactically, which means when you look at a high-…
Mark Abadi,Barbara Corbellini…
3 mins read
WeWork's IPO woes are bleeding into the biotech market - and health startups' plans to go public now look dimmer
Swiss biotechnology company ADC Therapeutics pulled its IPO on October 2, while those that have gon…
Trista Kelley,Lydia Ramsey
3 mins read
Where to go to donate your blood plasma if you've recovered from the coronavirus
If you are recovered from COVID-19, you might want to donate some of your plasma to help other sick…
Shira Feder
6 mins read
Dispensed: Approaching New York's peak, the path back to 'normal,' and the economic realities of the pandemic for healthcare
I hope for those who are celebrating holidays around now have found some way to keep the celebratio…
Lydia Ramsey
4 mins read
Dispensed: A secret patch, a $31 million pay package, and Amazon's ambitions in a $300 billion healthcare-technology market
And a quick Friday update on the urgent care front: Last week, I took a look at the industry overal…